Justin Chung

Recommended Articles

• Can You and Your Child Benefit from a Life Coach?

  It is not easy being the parent of a child with autism. There are joyous moments, of course, but there is no denying that there are also challenges. You constantly worry about your children and fight to provide them with the best physical, mental, and emotional care. In doing so, you may have...

• Diagnosis and Treatment of Leukemia

  Leukemia is defined as the cancer of blood or bone marrow which is responsible for the production of blood cells. A person who has leukemia generally suffers from an abnormal production of blood cells, especially leukocytes, also known as white blood cells, that are responsible for protecting the...

• California Judge Reverses $417 Million Lawsuit Against Johnson & Johnson

  For a long time, Johnson & Johnson had been accused of not properly labeling their products. Namely, they have many products that contain a substance known as talc, which may carry risks for cancer. A few months back, a woman with ovarian cancer filed a lawsuit against the American-based,...

• Mr. T's Lessons on Life and Lymphoma

  There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...

• What Foods Contribute to Sculpted Muscles?

  The raw materials needed for the building muscles are provided by food and not by physical activity. Building muscles requires adequate hydration, the right kind of foods, along with working out at the gym regularly. Another common misconception is that protein-rich food is the most important...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...